Compare Aurora Cannabis Inc (ACB) vs Rush Street Interactive Inc (RSI) Price & Performance

Aurora Cannabis (ACB) trades at $2.71, down 4.58% on the day, with a bearish technical outlook. The company reported a net income of $1.59 million in 2025, a significant improvement from a $69 million loss in 2024, though 2026 guidance projects a net loss of $136 million. Revenue grew to $343.29 million in 2025, but faces headwinds from Canadian reimbursement pressures. Analyst consensus is mixed, with 21.43% buy, 57.14% hold, and 21.43% sell ratings.

The stock's low P/B of 0.47 suggests undervaluation, but negative profitability metrics and a projected reset year in 2027 pose risks. Investment appeal hinges on execution in high-margin international medical markets, though volatility and competitive pressures remain key concerns for shareholders.

RSI trades at $32.22, up 1.7% on the day, with strong technical momentum and bullish moving averages. The company reported Q1 2026 EPS of $0.14, beating estimates, and revenue growth to $1.13B in 2025. Analyst consensus is a Buy with a $29.11 target, though high P/E of 94.76 signals premium valuation. Recent news highlights operational strength and a $100M share repurchase program.

Outlook is positive given earnings beats and sector tailwinds, but risks include elevated valuation and competitive pressures. Net income margin of 2.98% remains thin, requiring sustained growth to justify multiples. Institutional sentiment is bullish, with 10 Buy ratings, supporting near-term upside if execution continues.